May 1, 2026
1 min read

FDA Permits Expanded Access for Investigational Pancreatic Cancer Drug Daraxonrasib MedNews

Today, the U.S. Food and Drug Administration is announcing that it issued a safe to proceed letter to Revolution Medicines, allowing the sponsor to initiate an

Leave a Reply

Your email address will not be published.

Previous Story

Allied health services availability and human milk nutrition among preterm infants

Next Story

Nutrition program helps people access fresh food in qathet

Previous Story

Allied health services availability and human milk nutrition among preterm infants

Next Story

Nutrition program helps people access fresh food in qathet

Latest from Blog

Go toTop